AARD EPS Estimates
Aardvark Therapeutics, Inc. Common Stock
$3.98
+$0.10(+2.50%)
29
Overall
60
Value
10
Tech
18
Quality
Market Cap
$84.91M
Volume
3.21K
52W Range
$3.35 - $16.60
Target Price
$11.11
AARD EPS estimates: the consensus estimate for Aardvark Therapeutics, Inc. Common Stock's current fiscal year is -$3.17 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AARD EPS Estimates
- EPS estimate, current quarter
- $-0.74
- EPS estimate, next quarter
- $-0.73
- EPS estimate, current year
- $-3.17
- EPS estimate, next year
- $-2.52
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.93 |
| 2024 | $-5.15 |
| 2023 | $-1.82 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AARD | $3.98 | +2.5% | 3.21K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aardvark Therapeutics, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW